Viewing Study NCT04366492


Ignite Creation Date: 2025-12-24 @ 3:41 PM
Ignite Modification Date: 2025-12-24 @ 3:41 PM
Study NCT ID: NCT04366492
Status: COMPLETED
Last Update Posted: 2020-04-29
First Post: 2020-02-05
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: HBV/HCV/HIV in Belgian Prisons
Sponsor: Hasselt University
Organization:

Study Overview

Official Title: Prevalence of Blood Borne Viral Infections (HBV/HCV/HIV) in the Belgian Prison System
Status: COMPLETED
Status Verified Date: 2020-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To assess the prevalence of blood-borne viral infections in prisons in Belgium, screening will be executed in several prisons in Flanders, Brussels and Wallonia to obtain a geographical representative distribution.

Upon informed consent screening will be performed using whole capillary blood (finger prick testing) with three different tests for HCV Ab, HBsAg and HIV. Screening will be performed first. While awaiting the test result (15-20min), the participant can fill out a questionnaire (together with the study nurse), concerning risk factors for HCV, HBV and HIV infection. This questionnaire is filled out directly online, and will be immediately implemented in the encoded database. The database is set-up according to the rules of good clinical practice. (Castor EDC software). The results will be filled out immediately by the prison staff in this database after it is filled out by the participant, minimizing the risk of displacement of test results.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: